A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.
Market Scope
Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis
Latest Reports Latest News
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register Today
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 61
Comprehensive Pages
- 906
Cataract Surgeons Represented
- 189
Responses Analyzed
Latest Industry News & Trends
7/2/2020
MergerOrthopedic
UK Competition & Markets Authority Questions Stryker/Wright Merger
The United Kingdom Competition & Markets Authority (CMA) issued a statement of concern on June 30 regarding the Stryker and Wright Medical merger that is scheduled to take place later this year. Ba...
7/1/2020
OphthalmicPress Release
COVID-19 Impact Varies Across China’s Ophthalmic Sectors
.jpg)
Renewed lockdown measures in parts of three northeastern provinces of China in mid-May underscore the difficulty in predicting how COVID-19 will affect daily life and business in China, including o...
7/2/2020
BreakingCataractFundingOphthalmic
LayerBio Gets $3 Million From US Pentagon to Advance Drug-Eluting OcuRing for IOL Haptic
LayerBio announced July 1 that it had received a $3 million Technology/Therapeutic Development Award from the US Department of Defense to develop its OcuRing drug delivery platform for cataract sur...
7/2/2020
BreakingCataractOphthalmicRegulation
Santen, NTC Advance Post-Cataract Combination Eye Drop in Europe
Japan’s Santen and NTC, of Milan, Italy, announced June 29 the completion of the European decentralized procedure for marketing authorization of Ducressa, a fixed-dose combination of levofloxacin a...
7/3/2020
BreakingOphthalmicRegulation
Novartis Moves Away from Paying Physician Speakers, as it Settles Old Investigations
Novartis reported July 2 that it was moving away from the traditional speaker program model in the US, limiting the instances in which it pays external physicians to deliver education and eliminati...
7/2/2020
BreakingOphthalmicRegulationRetina
SparingVision Gets EU Orphan Designation for RP Therapy
SparingVision announced June 30 that the European Commission granted orphan drug designation to its SPVN06 therapy for the treatment of retinitis pigmentosa (RP). The French company said the decisi...
7/2/2020
BreakingOphthalmicPharmaRegulation
Roche’s Enspryng Approved in Japan for Adults and Children with NMOSD
Swiss drugmaker Roche announced June 29 that Japan’s regulators had approved Enspryng (satralizumab) for the prevention of relapses of neuromyelitis optica spectrum disorder (NMOSD) in aquaporin-4 ...
7/2/2020
BreakingFundingMergersOphthalmicRefractiveRetina
Ocuphire Gains Nasdaq Listing in Rexahn Merger Deal
Privately held Ocuphire Pharma and Nasdaq-listed Rexahn Pharmaceuticals announced June 17 that they had agreed to merge in an all-stock transaction, with the combined entity taking the name Ocuphir...
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.